Posts Tagged 'Actos bladder cancer'

Jury hearing arguments in Actos bladder cancer lawsuit

The first Actos bladder cancer lawsuit trial is underway in California, where a jury is hearing arguments from a patient who developed bladder cancer after using the diabetes medication. Jack Cooper took Actos for two years before developing bladder cancer.

Read more about the Actos bladder cancer lawsuit…

Takeda’s Actos diabetes drug tied to cancer, jury is told

Takeda Pharmaceutical Co. (4502), Asia’s biggest drugmaker, hid the cancer risks of its Actos drug to protect billions in sales, a jury was told in the first of more than 3,000 lawsuits over the diabetes medication to go to trial. Jurors may begin deliberating as early as today over whether Takeda should be held liable for failing to properly warn patients and their doctors that Actos could cause bladder cancer.

Read more about the Actos bladder cancer lawsuits…

Hissey Kientz publishes frequently asked questions for Actos bladder cancer

Hissey Kientz law firm has published a frequently asked questions section to provide more information about the diabetes medication Actos and bladder cancer to readers. The FAQs include information concerning who should not take Actos and certain risks associated with the drug.

Read more about the connection between Actos and bladder cancer…

Judge allows company to sell generic Actos

A U.S. District Judge has allowed a company to begin immediately selling generic Actos, despite resistance from the Food and Drug Administration (FDA). Watson Pharmaceuticals will begin marketing the generic version of the top-selling type II diabetes drug Actos, which has come under fire for health concerns.

Read more about the generic version of Actos…

 

Watson Can Sell Generic Actos Now, U.S. Judge Rules

Watson Pharmaceuticals Inc. may begin immediately marketing a generic version of Takeda (4502) Pharmaceutical Inc.’s diabetes drug Actos, a federal judge ruled, handing the U.S. Food and Drug Administration a defeat. U.S. District Judge Amy Berman Jackson in Washington today overturned an FDA decision that kept Watson from joining a period of shared exclusivity granted to the companies that are first to file for the right to market generic versions of branded drugs.

Read more about the new generic version of Actos…

AARP questions safety of Actos

The American Association of Retired Persons (AARP) has released a newsletter in which a segment called “Ask the Pharmacist” questions the safety of diabetes drug Actos. Dr. Armon B. Neel Jr. highlighted the risks of taking the drug, which have recently been at the center of Actos lawsuits.

Read more about the AARP Actos warning…

Consumer Reports warns against generic version of Actos

Consumer Reports has warned readers against using a generic version of Actos recently approved by the Food and Drug Administration. The consumer awareness organization recommends that patients ask their doctors if using the brand-name diabetes drug Actos or its new generic equivalent is necessary, and recommends it only for patients who have no other options.

Read more about the generic version of Actos…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.